Gregory M M Videtic

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. doi request reprint 30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancer
    Gregory M M Videtic
    Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio Electronic address
    Int J Radiat Oncol Biol Phys 90:203-8. 2014
  2. doi request reprint The role of stereotactic radiotherapy in the treatment of oligometastases
    Gregory M M Videtic
    The Cleveland Clinic, Cleveland, OH, USA
    Curr Oncol Rep 16:391. 2014
  3. doi request reprint Stereotactic body radiation therapy-based treatment model for stage I medically inoperable small cell lung cancer
    Gregory M M Videtic
    Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio Electronic address
    Pract Radiat Oncol 3:301-6. 2013
  4. doi request reprint The role of radiation therapy in small cell lung cancer
    Gregory M M Videtic
    Department of Radiation Oncology, Taussig Cancer Institute, The Cleveland Clinic, 9500 Euclid Avenue, Mailroom T28, Cleveland, OH 44195, USA
    Curr Oncol Rep 15:405-10. 2013
  5. doi request reprint A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung cancer
    Gregory M M Videtic
    Department of Radiation Oncology T28, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Support Care Cancer 21:211-8. 2013
  6. doi request reprint Locally advanced non-small cell lung cancer: what is the optimal concurrent chemoradiation regimen?
    Gregory M M Videtic
    Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Cleve Clin J Med 79:eS32-7. 2012
  7. doi request reprint The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient?
    Gregory M M Videtic
    Cleveland Clinic Lerner College of Medicine, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Oncol Rep 12:235-41. 2010
  8. doi request reprint Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control
    Gregory M M Videtic
    Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 77:344-9. 2010
  9. doi request reprint Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: small-cell lung cancer (SCLC)
    Gregory M M Videtic
    Department of Radiation Oncology, The Cleveland Clinic, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 72:327-34. 2008
  10. ncbi request reprint Primary malignant mesothelioma of the abdominal wall: complete response with radiotherapy alone
    Gregory M M Videtic
    Department of Radiation Oncology T28, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA
    Technol Cancer Res Treat 7:41-4. 2008

Collaborators

Detail Information

Publications41

  1. doi request reprint 30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancer
    Gregory M M Videtic
    Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio Electronic address
    Int J Radiat Oncol Biol Phys 90:203-8. 2014
    ..To review outcomes of 2 single-fraction lung stereotactic body radiation therapy (SBRT) schedules used for medically inoperable early stage lung cancer...
  2. doi request reprint The role of stereotactic radiotherapy in the treatment of oligometastases
    Gregory M M Videtic
    The Cleveland Clinic, Cleveland, OH, USA
    Curr Oncol Rep 16:391. 2014
    ....
  3. doi request reprint Stereotactic body radiation therapy-based treatment model for stage I medically inoperable small cell lung cancer
    Gregory M M Videtic
    Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio Electronic address
    Pract Radiat Oncol 3:301-6. 2013
    ..To report on medically inoperable stage I small cell lung cancer (SCLC) patients for whom stereotactic body radiation therapy (SBRT) was employed to manage the primary tumor...
  4. doi request reprint The role of radiation therapy in small cell lung cancer
    Gregory M M Videtic
    Department of Radiation Oncology, Taussig Cancer Institute, The Cleveland Clinic, 9500 Euclid Avenue, Mailroom T28, Cleveland, OH 44195, USA
    Curr Oncol Rep 15:405-10. 2013
    ..Current phase III trials in SCLC RT include studies looking at the optimal dose and target for limited disease and the role of thoracic RT in extensive disease. ..
  5. doi request reprint A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung cancer
    Gregory M M Videtic
    Department of Radiation Oncology T28, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Support Care Cancer 21:211-8. 2013
    ..The study seeks to prospectively evaluate pulmonary function and quality of life (QOL) in medically inoperable early-stage lung cancer patients undergoing stereotactic body radiotherapy (SBRT)...
  6. doi request reprint Locally advanced non-small cell lung cancer: what is the optimal concurrent chemoradiation regimen?
    Gregory M M Videtic
    Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Cleve Clin J Med 79:eS32-7. 2012
    ..Biologic therapies have yet to show value as add-on treatment to chemoradiation...
  7. doi request reprint The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient?
    Gregory M M Videtic
    Cleveland Clinic Lerner College of Medicine, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Oncol Rep 12:235-41. 2010
    ..Ongoing prospective trials are exploring dose and fractionation schedules in the inoperable population, and are starting to explore the role of SBRT for the operable patient...
  8. doi request reprint Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control
    Gregory M M Videtic
    Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 77:344-9. 2010
    ..To validate the use of stereotactic body radiotherapy (SBRT) using intensity-modulated radiotherapy (IMRT) beams for medically inoperable Stage I lung cancer...
  9. doi request reprint Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: small-cell lung cancer (SCLC)
    Gregory M M Videtic
    Department of Radiation Oncology, The Cleveland Clinic, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 72:327-34. 2008
    ....
  10. ncbi request reprint Primary malignant mesothelioma of the abdominal wall: complete response with radiotherapy alone
    Gregory M M Videtic
    Department of Radiation Oncology T28, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA
    Technol Cancer Res Treat 7:41-4. 2008
    ..The present case suggests that radiotherapy alone can provide sustained local control of mesothelioma...
  11. doi request reprint Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classification
    Gregory M M Videtic
    Department of Radiation Oncology, Taussig Cancer Institute, The Cleveland Clinic, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 75:1141-7. 2009
    ....
  12. ncbi request reprint Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation
    Gregory M M Videtic
    Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 57:709-16. 2003
    ..We then looked at the impact on patient outcomes of changing the RT during the course of the decade to a "conventionally" (2 Gy) fractionated regimen, with a focus on toxicity and survival rates...
  13. ncbi request reprint Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases
    Gregory M M Videtic
    Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 67:240-3. 2007
    ..Clinical trials for patients with brain metastases generally exclude small-cell lung cancer (SCLC) cases. We hypothesize that the RPA classes are valid in the setting of SCLC brain metastases...
  14. ncbi request reprint Impaired diffusion capacity predicts for decreased treatment tolerance and survival in limited stage small cell lung cancer patients treated with concurrent chemoradiation
    Gregory M M Videtic
    Department of Radiation Oncology T28, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Lung Cancer 43:159-66. 2004
    ....
  15. ncbi request reprint Primary chemoradiation as definitive treatment for unresectable cancer of the trachea
    Gregory M M Videtic
    Department of Radiation Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    Can Respir J 10:143-4. 2003
    ..Two years later, the patient was free of disease. Primary chemoradiation appears to be effective in managing locally advanced tracheal cancer...
  16. ncbi request reprint Does sex influence the impact that smoking, treatment interruption and impaired pulmonary function have on outcomes in limited stage small cell lung cancer treatment?
    Gregory M M Videtic
    Dept of Radiation Oncology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Can Respir J 12:245-50. 2005
    ..To look for survival differences between men and women with limited stage small cell lung cancer (LS-SCLC) by examining stratified variables that impair treatment efficacy...
  17. doi request reprint A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer
    Cristina P Rodriguez
    Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA
    J Thorac Oncol 5:229-35. 2010
    ..This phase II study added gefitinib (G) to our previously tested CCRT regimen in an effort to improve these outcomes...
  18. doi request reprint Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction
    David J Adelstein
    Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA
    J Thorac Oncol 4:1264-9. 2009
    ..Mature results are presented from a phase II trial of postoperative concurrent chemoradiotherapy in patients with poor-prognosis cancer of the esophagus and gastroesophageal junction after primary surgical resection...
  19. doi request reprint A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience
    Kevin L Stephans
    Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Thorac Oncol 4:976-82. 2009
    ..To assess the impact of fractionation upon tumor control and toxicity in medically inoperable early stage lung cancer patients treated with stereotactic body radiotherapy...
  20. doi request reprint Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients
    Kevin L Stephans
    Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Thorac Oncol 4:838-44. 2009
    ..To assess for variables predicting pulmonary function test (PFT) changes after stereotactic body radiotherapy (SBRT) for medically inoperable stage I lung cancer...
  21. doi request reprint Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy
    Michael J Burdick
    Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 78:1033-9. 2010
    ....
  22. doi request reprint Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort
    Gregory M M Videtic
    Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH, USA
    Int J Radiat Oncol Biol Phys 72:702-6. 2008
    ..We used the results of mediastinoscopy from a Stage III NSCLC cohort to assess the reliability of positron emission tomography (PET) scans at identifying involved mediastinal lymph nodes (MLN) when used during radiotherapy planning...
  23. ncbi request reprint Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival
    Gregory M M Videtic
    Department of Radiation Oncology, Brigham and Women s Hospital, 75 Francis St, ASBI, L2, Boston, MA 02115, USA
    J Clin Oncol 21:1544-9. 2003
    ..To determine the impact of continued smoking by patients receiving chemotherapy (CHT) and radiotherapy (RT) for limited-stage small-cell lung cancer (LSCLC) on toxicity and survival...
  24. doi request reprint Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes
    Neil M Woody
    Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA
    Int J Radiat Oncol Biol Phys 83:427-34. 2012
    ..This study developed a predictive model of chest wall pain incorporating radiobiologic effects, using clinical data from four distinct SBRT fractionation schemes...
  25. pmc Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239
    Ritsuko Komaki
    Department of Radiation Oncology, Unit 97, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 83:e531-6. 2012
    ....
  26. doi request reprint Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT)
    Kevin L Stephans
    Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 82:974-80. 2012
    ..To determine patient, tumor, and treatment factors related to the development of late chest wall toxicity after lung stereotactic body radiotherapy (SBRT)...
  27. ncbi request reprint A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity
    David J Adelstein
    The Taussig Cancer Center and the Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Am J Clin Oncol 30:172-80. 2007
    ..A split course of pre- and postoperative hyperfractionated radiation therapy and concurrent chemotherapy was used in an effort to limit perioperative mortality...
  28. ncbi request reprint Five-year survivors of brain metastases: a single-institution report of 32 patients
    Samuel T Chao
    Department of Radiation Oncology, Brain Tumor Institute, Taussig Cancer Center, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 66:801-9. 2006
    ..To report on 32 patients who survived > or = 5 years from brain metastases treated at a single institution...
  29. ncbi request reprint Brain metastases in small cell lung cancer
    Aimee L Quan
    Department of Radiation Oncology, Cleveland Clinic, Gamma Knife Center, Brain Tumor Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Oncology (Williston Park) 18:961-72; discussion 974, 979-80, 987. 2004
    ..For patients with a complete response to initial treatment, prophylactic cranial irradiation is an effective method of prevention...
  30. pmc Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease
    Aaron H Wolfson
    Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Int J Radiat Oncol Biol Phys 81:77-84. 2011
    ....
  31. doi request reprint ACR Appropriateness Criteria® Induction and Adjuvant Therapy for N2 Non-small-cell Lung Cancer
    Henning Willers
    Massachusetts General Hospital, Boston, MA University of North Carolina Health Care System, American Society of Clinical Oncology, Chapel Hill, NC Indiana University School of Medicine, Indianapolis, IN Henry Ford Health System Henry Ford Hospital, Detroit, MI 21st Century Oncology Michigan Healthcare Professionals, Farmington Hills, MI Society of Thoracic Surgeons, Columbia University, New York, NY Memorial Sloan Kettering Cancer Center, New York, NY Mount Sinai School of Medicine, New York, NY Stanford University and Stanford Cancer Institute, Stanford, CA Cleveland Clinic Foundation, Cleveland, OH University of Texas MD Anderson Cancer Center, Houston, TX
    Am J Clin Oncol 38:197-205. 2015
    ..Induction chemotherapy followed by surgery +/- PORT may also be an option in N2 patients. For preoperative RT and PORT, 3-dimensional conformal techniques and intensity-modulated RT are most appropriate. ..
  32. doi request reprint Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity
    Kevin L Stephans
    Department of Radiation Oncology, Cleveland Clinic, Taussig Cancer Center, Cleveland, Ohio Electronic address
    Int J Radiat Oncol Biol Phys 90:197-202. 2014
    ..To identify factors associated with grade ≥3 treatment related late esophageal toxicity after lung or liver stereotactic body radiation therapy (SBRT)...
  33. doi request reprint A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesoph
    Michael J McNamara
    Cleveland Clinic, Taussig Cancer Institute, Solid Tumor Oncology, Cleveland, OH Cleveland Clinic, Taussig Cancer Institute, Radiation Oncology, Cleveland, OH Cleveland Clinic, Heart and Vascular Institute, Thoracic and Cardiovascular Surgery, Cleveland, OH Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA and Cleveland Clinic, Quantitative Health Sciences, Cleveland, OH
    J Thorac Oncol 9:1561-7. 2014
    ..Distant failure remains common, however, suggesting potential benefit from additional chemotherapy. This phase II study investigated the addition of induction chemotherapy to surgery and adjuvant chemoradiotherapy...
  34. doi request reprint Lung stereotactic body radiation therapy: regional nodal failure is not predicted by tumor size
    Gaurav Marwaha
    Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
    J Thorac Oncol 9:1693-7. 2014
    ..To examine regional nodal failure patterns with respect to lesion size in medically inoperable early-stage non-small cell lung cancer (NSCLC) patients treated with definitive lung stereotactic body radiation therapy (SBRT)...
  35. doi request reprint The efficacy of external beam radiotherapy and stereotactic body radiotherapy for painful spinal metastases from renal cell carcinoma
    Grant K Hunter
    Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio
    Pract Radiat Oncol 2:e95-e100. 2012
    ..We compared the efficacy and durability of pain relief produced by these 2 modalities...
  36. ncbi request reprint Primary carcinoid tumors of the lung: a role for radiotherapy
    Heath B Mackley
    Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio, USA
    Oncology (Williston Park) 20:1537-43; discussion 1544-5, 1549. 2006
    ..Definitive radiation is warranted in unresectable disease. Palliative radiation for symptomatic lesions has demonstrated efficacy for all histologies. Collaborative group trials are warranted...
  37. doi request reprint Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT
    Jason W D Hearn
    Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio Electronic address
    Int J Radiat Oncol Biol Phys 90:402-6. 2014
    ..We report the safety and efficacy of SBRT for salvage of local failure after previous SBRT with a biologically effective dose (BED) of ≥ 100 Gy10...
  38. doi request reprint ACR appropriateness Criteria® early-stage non-small-cell lung cancer
    Gregory M M Videtic
    Cleveland Clinic Foundation, Cleveland, OH MD Anderson Cancer Center, Houston, TX Henry Ford Health System, Detroit, MI Department of Surgery, Columbia University Society of Thoracic Surgeons, New York, NY 21st Century Oncology Michigan Healthcare Professionals, Farmington Hills, MI University of Michigan and Ann Arbor Veteran Affairs Medical Center, Ann Arbor, MI Department of Radiation Oncology, University of Miami, Miami, FL Stanford University and Stanford Cancer Institute, Stanford, CA University of North Carolina Health Care System American Society of Clinical Oncology, Chapel Hill, NC Massachusetts General Hospital, Boston, MA Mount Sinai School of Medicine, New York, NY
    Am J Clin Oncol 37:201-7. 2014
    ..In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. ..
  39. ncbi request reprint Radiation recall dermatitis after the use of the anorexiant phentermine in a patient with breast cancer
    Robert B Ash
    Breast J 12:186-7. 2006
  40. ncbi request reprint Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
    Edward Yu
    Department of Radiation Oncology, London Regional Cancer Centre, 790 Commissioners Road, E, London, Ont, Canada N6A 4L6
    Radiother Oncol 73:141-8. 2004
    ..To assess the impact of extended volume radiation therapy (RT) with anastomotic coverage on local control in high risk post-operative esophageal cancer patients...
  41. doi request reprint Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: non-small-Cell lung cancer (NSCLC)
    Jose S A Belderbos
    Department of Radiation Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 72:335-42. 2008
    ..The purpose of this report is to analyze the current status of ENI and to provide comprehensive in-depth analysis and guidance on how to generally approach this issue in NSCLC...